HOME >> BIOLOGY >> NEWS
In a tiny squid, bacterial toxin governs organ development

MADISON - In a tiny Pacific Ocean squid, a toxic molecule that causes whooping cough and gonorrhea in humans has been found to be a critical catalyst for organ development.

The toxin, produced by different types of bacteria in different hosts, is known as tracheal cytotoxin. And the astonishing discovery that it can be either good or bad - depending on its biological context - promises to rattle long-held perceptions of microbes and their role as pathogens.

The new work, funded by the National Institutes of Health, was reported this week (Nov. 12) in the journal Science.

That the same toxic molecule produced by different bacteria in different host animals plays such disparate roles - disease and massive tissue damage on the one hand, and critical organ development on the other - may force biologists to rethink the relationship between the world's many microorganisms and their host plants and animals, according to Margaret McFall-Ngai, a University of Wisconsin-Madison professor of medical microbiology and the corresponding author of the Science paper.

"It is all context dependent," says McFall-Ngai. "It has to be that we have mechanisms to use these molecules in different ways. Until now, molecules of a virulent nature have not been recognized as having essential roles in development."

In the diminutive Hawaiian bobtail squid, the toxin was found to spur the development of a structure, a light-producing organ that acts as a sort of "Klingon cloaking device," mimicking starlight to confuse hungry predators lurking in the depths. In humans, the same toxic molecule, produced by different species of bacteria, causes massive tissue damage in the lungs in the case of whooping cough, and in the fallopian tubes in the case of gonorrhea.

When the squid are born, they are about half the size of a grain of rice, and they must acquire the toxin-producing bacteria from their oc
'"/>

Contact: Margaret McFall-Ngai
mjmcfallngai@wisc.edu
608-262-2393
University of Wisconsin-Madison
11-Nov-2004


Page: 1 2 3

Related biology news :

1. A new plant-bacterial symbiotic mechanism promising
2. UCF professor finds bacterial pathogen may be key to understanding cancer development
3. Researchers discover acquired DNA key to certain bacterial infection
4. Hot on the TRAIL of controlling inflammation in bacterial meningitis
5. A new plant-bacterial symbiotic mechanism promising for crop applications
6. Researchers develop way to calculate speed of bacterial sex
7. Gallium: A new antibacterial agent?
8. New antibacterials being developed to tackle MRSA superbug
9. The pull of bacterial chromosome segregation
10. Green plants share bacterial toxin
11. ASU researchers test antibacterial effects of healing clays

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: tiny squid bacterial toxin governs organ development

(Date:7/8/2015)... , July 8, 2015 Summary ... and the fourth most fatal, with a mortality rate ... poor prognosis of pancreatic cancer patients has highlighted a ... which is not being met by the current market. ... array of products with varying molecule types and mechanisms ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/30/2015)... VANCOUVER, Washington , July 30, 2015 ... "Biosimulation Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, ... (Drug Discovery & Development, Preclinical, Clinical Trial), by End ... the Biosimulation Market is expected to reach USD 2,107.99 ... at a CAGR of 15.29%. Browse ...
(Date:7/30/2015)... over 60,000 customers across the globe, ISN improves the efficiency and effectiveness of contractor ... 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than ... Headquartered in Dallas, TX , ISN has additional offices in ...
(Date:7/30/2015)... York, NY (PRWEB) , ... July 30, 2015 , ... As part of its 2015 ... raw material and technical service business units, Whitehouse Laboratories is pleased to ... will be adjacent to the Container Center of Excellence and will be strictly dedicated to ...
(Date:7/29/2015)... , July 30, 2015 According ... Market - Growth, Trends & Forecasts (2015-2020), , published by ... US$ 30.25 billion by the end of 2020, with ... accounting for more than 40% of the global market size. ... at a CAGR of 13.7% during the period of (2015-2020). ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
Cached News: